99 related articles for article (PubMed ID: 4009498)
1. Effect of L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid on urinary excretion of methylmercury in the mouse.
Mulder KM; Kostyniak PJ
J Pharmacol Exp Ther; 1985 Jul; 234(1):156-60. PubMed ID: 4009498
[TBL] [Abstract][Full Text] [Related]
2. The inhibition of gamma-glutamyl transpeptidase from human pancreatic carcinoma cells by (alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501).
Allen L; Meck R; Yunis A
Res Commun Chem Pathol Pharmacol; 1980 Jan; 27(1):175-82. PubMed ID: 6102405
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and pharmacological effects of the fermentation-derived antitumor agent, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125).
Neil GL; Berger AE; McPartland RP; Grindey GB; Bloch A
Cancer Res; 1979 Mar; 39(3):852-6. PubMed ID: 427775
[No Abstract] [Full Text] [Related]
4. Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
Jayaram HN; Ardalan B; Deas M; Johnson RK
Cancer Res; 1985 Jan; 45(1):207-12. PubMed ID: 2578092
[TBL] [Abstract][Full Text] [Related]
5. Tubular secretion and reabsorption of mercury compounds in mouse kidney.
Tanaka-Kagawa T; Naganuma A; Imura N
J Pharmacol Exp Ther; 1993 Feb; 264(2):776-82. PubMed ID: 8094752
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, Acivicin (NSC 163501).
Meck RA; Clubb KJ; Allen LM; Yunis AA
Cancer Res; 1981 Nov; 41(11 Pt 1):4547-53. PubMed ID: 7306976
[TBL] [Abstract][Full Text] [Related]
7. Impaired biliary excretion and whole body elimination of methylmercury in rats with congenital defect in biliary glutathione excretion.
Ballatori N; Gatmaitan Z; Truong AT
Hepatology; 1995 Nov; 22(5):1469-73. PubMed ID: 7590665
[TBL] [Abstract][Full Text] [Related]
8. Acivicin. An antitumor antibiotic.
Poster DS; Bruno S; Penta J; Neil GL; McGovren JP
Cancer Clin Trials; 1981; 4(3):327-30. PubMed ID: 7026076
[TBL] [Abstract][Full Text] [Related]
9. Methylmercury removal in the dog during infusion of 2,3-dimercaptosuccinic acid (DMSA).
Kostyniak PJ
J Toxicol Environ Health; 1983; 11(4-6):947-57. PubMed ID: 6312064
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
11. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
12. The toxicity, distribution and elimination of methylmercury in mice following intracerebral injection.
Fair PH; Balthrop JE; Braddon-Galloway S
Neurotoxicology; 1987; 8(2):281-9. PubMed ID: 3601240
[TBL] [Abstract][Full Text] [Related]
13. Enhanced effect of an L-glutamine antagonist, L-(alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, by Acinetobacter L-glutaminase-L-asparaginase.
Holcenberg JS
Cancer Treat Rep; 1979 Jun; 63(6):1109-14. PubMed ID: 466650
[TBL] [Abstract][Full Text] [Related]
14. Sex- and age-related mouse toxicity and disposition of the amino acid antitumor agent, acivicin.
McGovren JP; Neil GL; Chan PJ; Stewart JC
J Pharmacol Exp Ther; 1981 Mar; 216(3):433-40. PubMed ID: 7205622
[TBL] [Abstract][Full Text] [Related]
15. Phase I and pharmacological study of acivicin by 24-hour continuous infusion.
Weiss GR; McGovren JP; Schade D; Kufe DW
Cancer Res; 1982 Sep; 42(9):3892-5. PubMed ID: 7105049
[TBL] [Abstract][Full Text] [Related]
16. L-[alphaS, 5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): a new amino acid antibiotic with the properties of an antagonist of L-glutamine.
Jayaram HN; Cooney DA; Ryan JA; Neil G; Dion RL; Bono VH
Cancer Chemother Rep; 1975; 59(3):481-91. PubMed ID: 1147
[TBL] [Abstract][Full Text] [Related]
17. Studies of the biochemical pharmacology of the fermentation-derived antitumor agent, (alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125).
Neil GL; Berger AE; Bhuyan BK; Blowers CL; Kuentzel SL
Adv Enzyme Regul; 1978; 17():375-98. PubMed ID: 757314
[No Abstract] [Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Dimethylvinyl Chloride (1-Chloro-2-Methylpropene) (CAS No. 513-37-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1986 Aug; 316():1-238. PubMed ID: 12748737
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of glutathione in urine and plasma: relevance to urinary metal excretion studies.
Mulder KM; Kostyniak PJ
J Anal Toxicol; 1985; 9(1):31-5. PubMed ID: 2858603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
